Angiocrine Bioscience, Inc.
Get Full AccessDescription
- Angiocrine Bioscience, Inc. (San Diego, CA) is an innovative cellular therapy company committed to changing the face of curative treatments through our E-CEL technology. We are transforming the standards of medical practice through our rationally designed, inspired by nature, therapeutic platforms designed to drive stem cell renewal in a variety of disease settings.Angiocrines core technology is licensed from Weill Cornell Medical College and was invented and developed by Professor Shahin Rafii, M.D. His work related to Angiocrine technology has been published in numerous peer-reviewed journals, including Cell Stem Cell, Nature, Cell and Blood.
-
Headquarters:3570 Carmel Mountain Road Suite 200, San Diego, California, United States
More -
Phone Number: +1 408-646-2265
-
Website: http://angiocrinebioscience.com/
-
Employees:24
-
Revenue:$10 - 50M
-
Legal Name:Angiocrine Bioscience, Inc.
-
Angiocrine Bioscience, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 325414 |
Show More
Frequently Asked Questions regarding Angiocrine Bioscience, Inc.
-
Where are Angiocrine Bioscience, Inc.'s Headquarters?
Angiocrine Bioscience, Inc.'s Headquarters are in 3570 Carmel Mountain Road Suite 200,San Diego,California,United States
-
What is Angiocrine Bioscience, Inc.'s phone number?
Angiocrine Bioscience, Inc.'s phone number is +1 408-646-2265
-
What is Angiocrine Bioscience, Inc.'s official website?
Angiocrine Bioscience, Inc.'s official website is http://angiocrinebioscience.com/
-
What is Angiocrine Bioscience, Inc.'s Revenue?
Angiocrine Bioscience, Inc.'s revenue is $10 - 50M
-
What is Angiocrine Bioscience, Inc.'s NAICS code?
Angiocrine Bioscience, Inc.'s NAICS code is 325414
-
How many employees are working in Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. has 24 employees
-
What is Angiocrine Bioscience, Inc.'s Industry?
Angiocrine Bioscience, Inc. is in the industry of Biotechnology
-
Who is Angiocrine Bioscience, Inc.'s Chief Financial Officer?
Angiocrine Bioscience, Inc.'s Chief Financial Officer is John Lomoro

